WuXi Biologics (Cayman) Inc (WXXWY)
3.67
-0.11
(-2.91%)
USD |
OTCM |
Nov 22, 14:27
WuXi Biologics Total Assets (Quarterly): 7.719B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 7.719B |
| June 30, 2024 | 7.719B |
| December 31, 2023 | 7.981B |
| June 30, 2023 | 7.188B |
| June 30, 2023 | 7.188B |
| December 31, 2022 | 7.184B |
| June 30, 2022 | 7.084B |
| June 30, 2022 | 7.084B |
| December 31, 2021 | 6.908B |
| June 30, 2021 | 6.741B |
| June 30, 2021 | 6.741B |
| December 31, 2020 | 4.433B |
| Date | Value |
|---|---|
| June 30, 2020 | 2.923B |
| June 30, 2020 | 2.923B |
| December 31, 2019 | 2.516B |
| June 30, 2019 | 1.482B |
| June 30, 2019 | 1.482B |
| December 31, 2018 | 1.365B |
| June 30, 2018 | 1.294B |
| June 30, 2018 | 1.294B |
| December 31, 2017 | 742.72M |
| June 30, 2017 | 830.89M |
| June 30, 2017 | 830.89M |
| December 31, 2016 | 285.80M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.516B
Minimum
Dec 2019
7.981B
Maximum
Dec 2023
6.155B
Average
7.084B
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Zai Lab Ltd | 985.35M |
| Sinovac Biotech Ltd | 12.90B |
| CASI Pharmaceuticals Inc | 63.62M |
| Adagene Inc | 100.78M |
| LakeShore Biopharma Co Ltd | 220.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.577B |
| Shareholders Equity (Quarterly) | 5.594B |
| Debt to Equity Ratio | 0.0531 |
| Current Ratio | 2.911 |
| Net Debt Paydown Yield | 0.59% |